O'Callaghan of Binswanger completes 28,580 s/f R&D space lease at 34 Commerce Way to Amgen

Timothy O'Callaghan of Binswanger has completed the lease of a 28,580 s/f R&D space at 34 Commerce Way to Amgen. The property, owned and operated by Cummings Properties, was formerly occupied by Calloway Labs for use in drug testing protocols. Built in 1976 with many recent upgrades, the flex R&D building is in excellent condition. Key features to the area include a business park setting and many local amenities. The property has highway access to both I-95 & I-93, and is located 12 miles north from Boston. Amgen is a multinational biopharmaceutical company and is the second largest independent biopharmaceutical firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to infections in patients undergoing cancer chemotherapy; and Embrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Headquartered in Philadelphia, with the local office in Natick MA, Binswanger is an international full-service real estate organization with offices worldwide throughout the United States, Canada, Latin America, Europe, the Middle East, and Asia.